Caraway Therapeutics to Participate in William Blair Biotech Focus Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway’s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent … [Read more…]

Asher Bio Appoints Independent Director Bob Deresiewicz, M.D., to its Board

  SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders, today announced the appointment of Bob Deresiewicz, M.D., to its Board of Directors. Dr. Deresiewicz is a recently retired partner, portfolio manager and global industry analyst with Wellington Management Company, LLP. … [Read more…]

The 3rd Annual MedExecWomen Meeting: Strategy, Vision, and Energy

BOSTON–(BUSINESS WIRE)–#medtech–Over 120 female senior medtech executives gathered on June 14 for MedExecWomen’s annual conference: “Into the Future: New Healthcare Partnerships to Drive Value.” MedExecWomen, co-founded in 2019 by Laurie Halloran, president & CEO of Halloran Consulting Group, and Maria Shepherd, president & founder of Medi-Vantage, empowers women in leadership roles in the medical device, … [Read more…]

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against the Most Prevalent Omicron Subvariants* in the US, BA.4/5 and BA.2.12.1

IMM-BCP-01 neutralized BA.4/.5 and BA.2.12.1 subvariants in pseudovirus testing IMM-BCP-01 currently in Phase 1b clinical testing with topline data expected in 2H 2022 EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that their cocktail (IMM-BCP-01) retained activity … [Read more…]

Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments

NEW YORK–(BUSINESS WIRE)–Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the promotion of Shirly Pinto, Ph.D., to Chief Scientific Officer and the appointments of Jiajun Liu, Ph.D., as Vice President and Head of Biometrics and Michael Crutchlow, M.D., as Vice President and Head of Translational … [Read more…]

BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies

BeiGene and InnoRNA will jointly research a number of mRNA-LNP programs, and BeiGene will hold exclusive global development and commercialization rights for the product candidates from the programs BeiGene will also gain a non-exclusive license to InnoRNA’s proprietary LNP Technology to support internal discovery efforts CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene (NASDAQ: … [Read more…]

Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment

ETTLINGEN, Germany–(BUSINESS WIRE)–$BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRisk PACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRisk PACS™ RuO test is promising … [Read more…]

Turnstone Biologics and Moffitt Cancer Center Announce Strategic Alliance to Advance Next-Generation TIL Therapies for Solid Tumors

Strategic alliance significantly expands ongoing multi-year collaboration by granting Turnstone broader access and enhanced benefits at Moffitt IND approval received for a Moffitt-sponsored Phase 1 study of TIDAL-01 in melanoma NEW YORK & TAMPA, Fla.–(BUSINESS WIRE)–#TIL–Turnstone Biologics Corp., a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, and Moffitt Cancer Center … [Read more…]

Global Zolpidem (CAS 82626-48-0) Market Analysis Report 2022: Trends and Developments, Prices, Patents, Manufacturing Methods, Major Players, Applications, Key Downstream Industries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Zolpidem (CAS 82626-48-0) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Zolpidem. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]

Tioclomarol (CAS 22619-35-8) Global Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Tioclomarol (CAS 22619-35-8) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Tioclomarol. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]